mr EVAN DORNER — Lobbyist Profile | Poliscope

mr EVAN DORNER

Filings

Clients

Firms

Years active

2022–2024

Associated filing income

$1,295,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
CODAGENIX	10	2022–2024
CIVICA RX	9	2022–2024
IGM BIOSCIENCES, INC.	9	2022–2024
PSYONIC	7	2023–2024
ENERGY SOURCE MINERALS	5	2024
ICHOR SCIENCES	5	2022–2023

Lobbying firms

Firm	Filings	Years
STRATEGIC MARKETING INNOVATIONS	64	2022–2024

Bills explicitly cited in this lobbyist’s assigned issues (2)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 8236

Pre-K for Kids Act of 2024

Client: USACA · Firm: STRATEGIC MARKETING INNOVATIONS

Open original LDA filing ↗

Cited source text

H.R. 8236 Funding for thermal protection materials manufacturing and development

H.R. 8255

To establish a minimum public comment period with respect to proposed rules issued by the Securities and Exchange Commission.

Client: USACA · Firm: STRATEGIC MARKETING INNOVATIONS

Open original LDA filing ↗

Cited source text

H.R. 8255 Funding for nuclear power generation sustainability, advanced turbine program, energy and water appropriations

Original LDA source filings (64)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

ENERGY SOURCE MINERALS via STRATEGIC MARKETING INNOVATIONS

2024 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Advanced materials processing technology

Filing targets: Defense, Dept of (DOD)

ENERGY SOURCE MINERALS via STRATEGIC MARKETING INNOVATIONS

2024 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Source: Senate LDA

Show 60 more original filings

ENERGY SOURCE MINERALS via STRATEGIC MARKETING INNOVATIONS

2024 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Advanced materials processing technology

Filing targets: Defense, Dept of (DOD)

DATELINE RESOURCES via STRATEGIC MARKETING INNOVATIONS

2024 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

NAT

Natural Resources

Pilot project for DPA Title III for rare earth mining in the US

DEF

Defense

Pilot project for DPA Title III for rare earth mining in the US

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2024 · second_quarter · Q2

Firm income: $15,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2024 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of vaccines for DOD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2024 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

DEF

Defense

Onshoring domestic pharmaceutical industrial base

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

PSYONIC via STRATEGIC MARKETING INNOVATIONS

2024 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

MED

Medical/Disease Research/Clinical Labs

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

DATELINE RESOURCES via STRATEGIC MARKETING INNOVATIONS

2024 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

NAT

Natural Resources

Pilot project for DPA Title III for rare earth mining in the US

DEF

Defense

Pilot project for DPA Title III for rare earth mining in the US

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2024 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2024 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of vaccines for DOD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2024 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

DEF

Defense

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ENERGY SOURCE MINERALS via STRATEGIC MARKETING INNOVATIONS

2024 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Advanced materials processing technology

Filing targets: Defense, Dept of (DOD)

ENERGY SOURCE MINERALS via STRATEGIC MARKETING INNOVATIONS

2024 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Advanced materials processing technology

DATELINE RESOURCES via STRATEGIC MARKETING INNOVATIONS

2023 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

DEF

Defense

Pilot project for DPA Title III for rare earth mining in the US

NAT

Natural Resources

Pilot project for DPA Title III for rare earth mining in the US

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

PSYONIC via STRATEGIC MARKETING INNOVATIONS

2023 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

MED

Medical/Disease Research/Clinical Labs

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

UMASS CHAN MEDICAL SCHOOL (FKA UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL) via STRATEGIC MARKETING INNOVATIONS

2023 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for military infectious disease research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2023 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2023 · fourth_quarter · Q4

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of vaccines for DOD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2023 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

DEF

Defense

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

DATELINE RESOURCES via STRATEGIC MARKETING INNOVATIONS

2023 · fourth_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

NAT

Natural Resources

Pilot project for DPA Title III for rare earth mining in the U.S.

UMASS CHAN MEDICAL SCHOOL (FKA UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL) via STRATEGIC MARKETING INNOVATIONS

2023 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for military infectious disease research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MABUS GROUP BEHALF OF XGS ENERGY (FKA XGS ENERGY) via STRATEGIC MARKETING INNOVATIONS

2023 · third_quarter · 3T

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for DOD geothermic energy

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2023 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2023 · third_quarter · Q3

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of vaccines for DOD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2023 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

DEF

Defense

Onshoring domestic pharmaceutical industrial base

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

PSYONIC via STRATEGIC MARKETING INNOVATIONS

2023 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

MED

Medical/Disease Research/Clinical Labs

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

ICHOR SCIENCES via STRATEGIC MARKETING INNOVATIONS

2023 · third_quarter · 3T

Firm income: $5,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Defense appropriations programmatic add

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

MABUS GROUP BEHALF OF SKYRYSE via STRATEGIC MARKETING INNOVATIONS

2023 · third_quarter · 3T

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for DOD flight control technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

USACA via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

DEF

Defense

H.R. 8236 Funding for thermal protection materials manufacturing and development

ENG

Energy/Nuclear

H.R. 8255 Funding for nuclear power generation sustainability, advanced turbine program, energy and water appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

PSYONIC via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MED

Medical/Disease Research/Clinical Labs

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

HCR

Health Issues

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

ICHOR SCIENCES via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Defense appropriations programmatic add

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

MABUS GROUP BEHALF OF SKYRYSE via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for DOD flight control technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

UMASS CHAN MEDICAL SCHOOL (FKA UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL) via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for military infectious disease research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MABUS GROUP BEHALF OF XGS ENERGY (FKA XGS ENERGY) via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for DOD geothermic energy

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of vaccines for DOD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2023 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

DEF

Defense

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

UMASS CHAN MEDICAL SCHOOL (FKA UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL) via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for military infectious disease research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of vaccines for DOD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

DEF

Defense

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MABUS GROUP BEHALF OF XGS ENERGY (FKA XGS ENERGY) via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · 1A

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for DOD geothermic energy

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MABUS GROUP BEHALF OF XGS ENERGY (FKA XGS ENERGY) via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for DOD geothermic energy

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MABUS GROUP BEHALF OF SKYRYSE via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for DOD flight control technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

MABUS GROUP BEHALF OF XGS ENERGY (FKA XGS ENERGY) via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for DOD geothermic energy

PSYONIC via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

MED

Medical/Disease Research/Clinical Labs

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

PSYONIC via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

MED

Medical/Disease Research/Clinical Labs

Receive DoD medical research funding on how to best apply prosthetic to the nervous system

ICHOR SCIENCES via STRATEGIC MARKETING INNOVATIONS

2023 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Defense appropriations programmatic add

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

UMASS CHAN MEDICAL SCHOOL (FKA UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL) via STRATEGIC MARKETING INNOVATIONS

2022 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Funding for military infectious disease research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2022 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2022 · fourth_quarter · Q4

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of Dengue Vaccine for DoD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2022 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

DEF

Defense

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ICHOR SCIENCES via STRATEGIC MARKETING INNOVATIONS

2022 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Defense appropriations programmatic add

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

ICHOR SCIENCES via STRATEGIC MARKETING INNOVATIONS

2022 · fourth_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Defense appropriations programmatic add

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2022 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2022 · third_quarter · Q3

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of Dengue Vaccine for DoD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2022 · third_quarter · Q3

Firm income: $5,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

DEF

Defense

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

SUMMERBIO via STRATEGIC MARKETING INNOVATIONS

2022 · second_quarter · 2T

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

COVID-19 Diagnostic National Testing

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IGM BIOSCIENCES, INC. via STRATEGIC MARKETING INNOVATIONS

2022 · second_quarter · 2A

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Antibody therapies

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CODAGENIX via STRATEGIC MARKETING INNOVATIONS

2022 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

Development of Dengue Vaccine for DoD

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CIVICA RX via STRATEGIC MARKETING INNOVATIONS

2022 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Onshoring domestic pharmaceutical industrial base

DEF

Defense

Onshoring domestic pharmaceutical industrial base

Filing targets: HOUSE OF REPRESENTATIVES, SENATE